메뉴 건너뛰기
Quality of Life Research
Volumn 15, Issue 3, 2006, Pages 425-426
Clinically important differences in Q-TWIST - One twist too many? Commentary
Author keywords

[No Author keywords available]
Indexed keywords

CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER RESEARCH; CANCER SURVIVAL; COMPARATIVE STUDY; CORRELATION ANALYSIS; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; DRUG SAFETY; MEASUREMENT; NOTE; PRIORITY JOURNAL; QUALITY ADJUSTED TIME WITHOUT SYMPTOMS OF DISEASE AND TOXICITY ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL TIME; TREATMENT OUTCOME;
EID: 33645105264     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-005-4672-z     Document Type: Note
Times cited : (3)
References (11)
  • 1
    • 0022330587 scopus 로고
    • Parameter estimates for a QALY utility model
    • 1. JM Miyamoto SA Eraker 1985 Parameter estimates for a QALY utility model Med Decis Making 5 191 213 1:STN:280:BimC2svgtlY%3D 3831640
    • (1985) Med Decis Making , vol.5 , pp. 191-213
    • Miyamoto, JM1    Eraker, SA2
  • 2
    • 85121074131 scopus 로고    scopus 로고
    • 2. P Kind 1996 The EuroQoL instrument: An index of health-related quality of Life B Spilker Quality of Life and Pharmacoeconomics in Clinical Trials 2 Lippincott-Raven Philadelphia 191 202
  • 3
    • 33645101095 scopus 로고    scopus 로고
    • Analyzing oncology clinical trial data using the Q-TWIST method: Clinical importance and sources for health state preference data
    • 3. DA Revicki D Feeny TL Hunt BF Cole 2006 Analyzing oncology clinical trial data using the Q-TWIST method: Clinical importance and sources for health state preference data Qual Life Res 15 411 423
    • (2006) Qual Life Res , vol.15 , pp. 411-423
    • Revicki, DA1    Feeny, D2    Hunt, TL3    Cole, BF4
  • 4
    • 0022873029 scopus 로고
    • A new endpoint for the assessment of adjuvant therapy in post-menopausal women with operable breast cancer
    • 4. RD Gelber A Goldhirsh 1986 A new endpoint for the assessment of adjuvant therapy in post-menopausal women with operable breast cancer J Clin Oncol 4 1772 1779 1:STN:280:BiiD2MbpsFA%3D 3783203
    • (1986) J Clin Oncol , vol.4 , pp. 1772-1779
    • Gelber, RD1    Goldhirsh, A2
  • 5
    • 0027200353 scopus 로고
    • Interpretation of quality of life changes
    • 5. E Lydick RS Epstein 1993 Interpretation of quality of life changes Qual Life Res 2 221 226 10.1007/BF00435226 1:STN:280:ByuD3cvotV0%3D 8401458
    • (1993) Qual Life Res , vol.2 , pp. 221-226
    • Lydick, E1    Epstein, RS2
  • 6
    • 0024852022 scopus 로고
    • Measurement of health status. Ascertaining the minimal clinically important difference
    • 6. R Jaeschke J Singer GH Guyatt 1989 Measurement of health status. Ascertaining the minimal clinically important difference Control Clin Trials 10 407 415 1:STN:280:By%2BC3cjks1c%3D 2691207
    • (1989) Control Clin Trials , vol.10 , pp. 407-415
    • Jaeschke, R1    Singer, J2    Guyatt, GH3
  • 7
    • 0034578738 scopus 로고    scopus 로고
    • Defining the clinically important difference in pain outcome measures
    • 7. JT Farrar RK Portenoy JA Berlin JL Kinman BL Strom 2000 Defining the clinically important difference in pain outcome measures Pain 88 287 294 10.1016/S0304-3959(00)00339-0 1:STN:280:DC%2BD3M7gtlSktQ%3D%3D 11068116
    • (2000) Pain , vol.88 , pp. 287-294
    • Farrar, JT1    Portenoy, RK2    Berlin, JA3    Kinman, JL4    Strom, BL5
  • 8
    • 0027417437 scopus 로고
    • The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology
    • 8. NK Aaronson S Ahmedzai B Bergman 1993 The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 365 376 1:STN:280:ByyC28vivVc%3D 8433390
    • (1993) J Natl Cancer Inst , vol.85 , pp. 365-376
    • Aaronson, NK1    Ahmedzai, S2    Bergman, B3
  • 9
    • 0031972496 scopus 로고    scopus 로고
    • Interpreting the significance of changes in health-related quality of life scores
    • 9. D Osoba G Rodrigues J Myles B Zee J Pater 1998 Interpreting the significance of changes in health-related quality of life scores J Clin Oncol 16 139 144 1:STN:280:DyaK1c7gtFKrtw%3D%3D 9440735
    • (1998) J Clin Oncol , vol.16 , pp. 139-144
    • Osoba, D1    Rodrigues, G2    Myles, J3    Zee, B4    Pater, J5
  • 10
    • 0028055059 scopus 로고
    • Determining a minimal important change in a disease-specific Quality of Life Questionnaire
    • 10. EF Juniper GH Guyatt A Willan LE Griffiths 1994 Determining a minimal important change in a disease-specific Quality of Life Questionnaire J Clin Epidemiol 47 81 87 10.1016/0895-4356(94)90036-1 1:STN:280:ByuC3M%2FotVY%3D 8283197
    • (1994) J Clin Epidemiol , vol.47 , pp. 81-87
    • Juniper, EF1    Guyatt, GH2    Willan, A3    Griffiths, LE4
  • 11
    • 0026543164 scopus 로고
    • Evaluation of impairment of health-related quality of life in asthma: Development of a questionnaire for use in clinical trials
    • 11. E Juniper GH Guyatt RS Epstein 1992 Evaluation of impairment of health-related quality of life in asthma: Development of a questionnaire for use in clinical trials Thorax 47 76 83 1:STN:280:By2C1MnnslU%3D 1549827
    • (1992) Thorax , vol.47 , pp. 76-83
    • Juniper, E1    Guyatt, GH2    Epstein, RS3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.